Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Cofactors and Coenzymes01:27

Cofactors and Coenzymes

88.3K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
88.3K
Cofactors and Coenzymes01:24

Cofactors and Coenzymes

13.0K
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
13.0K
Cancer Prevention02:59

Cancer Prevention

8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

4.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.2K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

4.0K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Monoclonal Antibody Targeting the A29 Protein of Monkeypox Virus and Its Application in Immunoassay.

Antibodies (Basel, Switzerland)·2026
Same author

A Validated LC-MS/MS Method for the Determination of Perospirone in Human Plasma and Its Pharmacokinetic Application in Healthy Volunteers.

ACS omega·2026
Same author

Inhibition of Toxoplasma gondii proliferation by dimethyl itaconate: Evidence from in vitro and in vivo studies.

PLoS neglected tropical diseases·2026
Same author

[Dynamics of the replication process of Akabane virus GZTS-1 strain in Vero cells].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2026
Same author

Associations of serum metal/metalloids with ovarian reserve and inflammation mediation: a repeated-measures longitudinal study.

Environment international·2026
Same author

PLO genomic diversity underpins differential immunogenicity of <i>Trueperella pyogenes</i> strains from deer and swine.

Frontiers in veterinary science·2026

Related Experiment Video

Updated: Mar 8, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K

Insights Into Highly Associated Co-Factors on HPV-Related Cervical Cancer.

Liyuan Zheng1, Guangwei Zhao2, Lili Zheng3

  • 1School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao, China.

Reviews in Medical Virology
|March 7, 2026
PubMed
Summary

Persistent high-risk human papillomavirus (HPV) infections drive cervical cancer. Co-factors like the microbiome and immunity influence HPV persistence, carcinogenesis, and treatment efficacy.

Keywords:
cervical cancerhuman leucocyte antigen genehuman papillomavirusmicrobiome

More Related Videos

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.7K
In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

16.4K

Related Experiment Videos

Last Updated: Mar 8, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.7K
In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

16.4K

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Cervical cancer is a leading malignancy affecting women globally.
  • Persistent high-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer.
  • HPV infections are often asymptomatic and vary in type and prevalence geographically.

Purpose of the Study:

  • To review key factors contributing to HPV-related cervical cancer.
  • To discuss the mechanisms by which these factors promote carcinogenesis.
  • To inform the development of improved prevention and treatment strategies.

Main Methods:

  • Literature review of studies on cervical cancer, HPV, and co-factors.
  • Analysis of mechanisms linking HPV infection, co-factors, and cancer development.
  • Synthesis of information on treatment efficacy influenced by these factors.

Main Results:

  • High-risk HPV types are strongly linked to cervical cancer incidence.
  • Microbiome, immune status, and geographic origin are significant co-factors.
  • These factors impact the effectiveness of chemotherapy and immunotherapy.

Conclusions:

  • Understanding co-factors is crucial for managing HPV-related cervical cancer.
  • Targeting these factors may lead to more effective preventive and therapeutic interventions.
  • Further research into the interplay of HPV and co-factors is warranted.